COSTA, FEDERICA
 Distribuzione geografica
Continente #
NA - Nord America 1.854
AS - Asia 1.535
EU - Europa 1.103
SA - Sud America 202
AF - Africa 105
Continente sconosciuto - Info sul continente non disponibili 2
Totale 4.801
Nazione #
US - Stati Uniti d'America 1.784
SG - Singapore 524
CN - Cina 441
VN - Vietnam 254
IT - Italia 218
SE - Svezia 199
IE - Irlanda 189
BR - Brasile 152
DE - Germania 112
HK - Hong Kong 98
FI - Finlandia 82
FR - Francia 76
ZA - Sudafrica 72
TR - Turchia 60
NL - Olanda 49
CA - Canada 47
BD - Bangladesh 45
GB - Regno Unito 35
AT - Austria 30
IN - India 25
AR - Argentina 19
CZ - Repubblica Ceca 17
RU - Federazione Russa 17
ES - Italia 13
PL - Polonia 13
PH - Filippine 12
CI - Costa d'Avorio 11
JP - Giappone 11
LT - Lituania 11
MX - Messico 11
RO - Romania 11
BE - Belgio 10
VE - Venezuela 8
PK - Pakistan 7
PY - Paraguay 7
TH - Thailandia 7
IQ - Iraq 6
KR - Corea 6
CL - Cile 5
IL - Israele 5
ID - Indonesia 4
KE - Kenya 4
KH - Cambogia 4
TW - Taiwan 4
UZ - Uzbekistan 4
AE - Emirati Arabi Uniti 3
AL - Albania 3
BO - Bolivia 3
CO - Colombia 3
EC - Ecuador 3
MA - Marocco 3
AM - Armenia 2
AZ - Azerbaigian 2
BG - Bulgaria 2
BY - Bielorussia 2
CH - Svizzera 2
CR - Costa Rica 2
EG - Egitto 2
ET - Etiopia 2
EU - Europa 2
GT - Guatemala 2
JM - Giamaica 2
MD - Moldavia 2
NG - Nigeria 2
PA - Panama 2
PT - Portogallo 2
SC - Seychelles 2
SM - San Marino 2
SN - Senegal 2
UA - Ucraina 2
AG - Antigua e Barbuda 1
BH - Bahrain 1
CG - Congo 1
CY - Cipro 1
DK - Danimarca 1
DO - Repubblica Dominicana 1
DZ - Algeria 1
GD - Grenada 1
GE - Georgia 1
HN - Honduras 1
HU - Ungheria 1
IR - Iran 1
JO - Giordania 1
KZ - Kazakistan 1
LY - Libia 1
MU - Mauritius 1
MY - Malesia 1
NP - Nepal 1
OM - Oman 1
PE - Perù 1
QA - Qatar 1
RS - Serbia 1
SI - Slovenia 1
TN - Tunisia 1
UY - Uruguay 1
YE - Yemen 1
Totale 4.801
Città #
Ashburn 264
Singapore 258
Chandler 218
Dublin 188
San Jose 145
Santa Clara 119
Parma 98
Hong Kong 93
Dallas 86
Beijing 83
Ho Chi Minh City 76
Ann Arbor 74
New York 74
Johannesburg 70
Hanoi 65
Shanghai 58
Dearborn 54
Los Angeles 48
Boardman 47
Munich 41
Izmir 38
Lauterbourg 36
Nanjing 36
Princeton 32
Helsinki 26
Vienna 25
Shenyang 23
Toronto 22
Wilmington 21
Marseille 18
Columbus 17
Council Bluffs 17
Turku 17
Buffalo 15
Da Nang 14
Jinan 14
Kunming 14
Moscow 14
Bremen 13
Hebei 13
Kocaeli 13
Nanchang 13
Brno 12
Chicago 12
Milan 12
Abidjan 11
Warsaw 11
Brussels 10
Frankfurt am Main 10
Jiaxing 10
Montreal 10
Orem 10
San Mateo 10
The Dalles 10
Brooklyn 9
Redmond 9
Tokyo 9
Focsani 8
Hefei 8
São Paulo 8
Tianjin 8
Zhengzhou 8
Changsha 7
Denver 7
London 7
Stockholm 7
Woodbridge 7
Amsterdam 6
Düsseldorf 6
Hangzhou 6
Houston 6
Modena 6
Poplar 6
Rome 6
Seattle 6
Chennai 5
Chongqing 5
Dhaka 5
Fairfield 5
Haiphong 5
Madrid 5
Ottawa 5
Palermo 5
Phoenix 5
Rio de Janeiro 5
Salvador 5
Ankara 4
Atlanta 4
Belo Horizonte 4
Boston 4
Can Tho 4
Des Moines 4
Jakarta 4
Mumbai 4
Norwalk 4
Phnom Penh 4
Rio Saliceto 4
San Francisco 4
Torino 4
Tân Tiến 4
Totale 2.999
Nome #
Dependence on glutamine uptake and glutamine addiction characterize myeloma cells: a new attractive target 220
CD14+CD16+ monocytes are involved in daratumumab-mediated myeloma cells killing and in anti-CD47 therapeutic strategy 196
The Proteasome and Myeloma-Associated Bone Disease 191
Bone marrow Dikkopf-1 levels are a new independent risk factor for progression in patients with smouldering myeloma 188
Osteolytic lesions, cytogenetic features and bone marrow levels of cytokines and chemokines in multiple myeloma patients: Role of chemokine (C-C motif) ligand 20 183
Expression of CD38 in myeloma bone niche: A rational basis for the use of anti-CD38 immunotherapy to inhibit osteoclast formation 182
EXPRESSION OF CD38 AND ECTOENZYMES OF THE ADENOSINERGIC PATHWAYS IN MYELOMA BONE NICHE: A RATIONAL BASIS FOR THE USE OF DARATUMUMAB TO TARGET OSTEOCLAST FORMATION IN MULTIPLE MYELOMA 174
ADENOSINE IN THE MYELOMA BONE MARROW NICHE: IMMUNE CHECKPOINT AND KEY PLAYER IN DISEASE PROGRESSION 167
Bone Marrow DKK-1 Levels in Smoldering Multiple Myeloma Patients: A New Independent Risk Factor for Progression 160
DEPENDENCE ON GLUTAMINE UPTAKE OF MYELOMA CELLS DELINEATES A NEW ATTRACTIVE THERAPEUTIC STRATEGY 159
Improved scaffold biocompatibility through anti-Fibronectin aptamer functionalization 157
LENALIDOMIDE INCREASES HUMAN DENDRITIC CELL MATURATION MODULATING BOTH MONOCYTE DIFFERENTIATION AND MESENCHYMAL STROMAL CELL INHIBITORY PROPERTIES 157
Myeloma Cells Deplete Bone Marrow Glutamine and Inhibit Osteoblast Differentiation Limiting Asparagine Availability 156
IL21R expressing CD14+CD16+ monocytes expand in multiple myeloma patients leading to increased osteoclasts 154
Expression Profile of CD38 and Related Ectoenzymes in Myeloma Bone Niche: A Rational Basis for the Use of Daratumumab to Inhibit Osteoclast Formation and Activity 153
PD-L1/PD-1 Pattern of Expression Within the Bone Marrow Immune Microenvironment in Smoldering Myeloma and Active Multiple Myeloma Patients 151
Lenalidomide increases human dendritic cell maturation in multiple myeloma patients targeting monocyte differentiation and modulating mesenchymal stromal cell inhibitory properties 146
Adenosine Generated in the Bone Marrow Niche Through a CD38-Mediated Pathway Correlates with Progression of Human Myeloma. 145
Novel Approaches to Improve Myeloma Cell Killing by Monoclonal Antibodies 144
Bone marrow CD14+ cells show different transcriptional profiles in Multiple Myeloma (MM) as compared to smoldering MM and MGUS: overexpression of IL21R and its involvement in osteoclastogenesis 141
The link between bone microenvironment and immune cells in multiple myeloma: Emerging role of CD38 140
CD38 Expression by Myeloma Cells and Its Role in the Context of Bone Marrow Microenvironment: Modulation by Therapeutic Agents 140
Oncolytic virotherapy and microenvironment in multiple myeloma 135
Lenalidomide Increases Human Dendritic Cell Maturation in Multiple Myeloma Modulating Both Monocyte Differentiation and Mesenchymal Stromal Cell Inhibitory Properties through Ikaros and Casein Kinase 1 Degradation, Respectively 134
Possible targets to treat myeloma-related osteoclastogenesis 133
Oncolytic Virotherapy in Multiple Myeloma: A Possible Alternative Role of Bovine Viruses 129
Il mieloma multiplo nell'era dei nuovi farmaci. Patogenesi 122
Immune response to SARS-CoV-2 mRNA vaccination and booster dose in patients with multiple myeloma and monoclonal gammopathies: impact of Omicron variant on the humoral response 113
PD-L1/PD-1 axis in multiple myeloma microenvironment and a possible link with CD38-mediated immune-suppression 110
CD38: A target for immunotherapeutic approaches in multiple myeloma 109
Overexpression of Pro-Osteoclastogenic Cytokine Receptors and Chemokines By Bone Marrow CD14(+) Monocytes of Multiple Myeloma (MM) Patients As Compared to Smoldering MM (SMM) and Monoclonal Gammopathy of Uncertain Significance (MGUS): Role of Interleukin(IL)-21 Receptor/IL-21 Axis in MM-Induced Osteoclastogenesis 103
Transcriptional and proteomic profiles of bone marrow CD14+ cells in multiple myeloma (MM) compared to smoldering MM and MGUS: overexpression of Interleukin (IL)-21 receptor and its involvement in MM-induced osteoclastogenesis 95
Microvesicles released from multiple myeloma cells are equipped with ectoenzymes belonging to canonical and non-canonical adenosinergic pathways and produce adenosine from ATP and NAD+ 92
Totale 4.879
Categoria #
all - tutte 17.336
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 17.336


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202129 0 0 0 0 0 0 0 0 0 0 0 29
2021/2022164 5 5 10 14 3 0 28 10 14 11 8 56
2022/2023805 90 93 64 70 63 86 29 49 223 7 22 9
2023/2024333 16 30 10 6 23 104 36 17 9 14 11 57
2024/2025942 15 39 41 107 103 94 53 47 125 70 92 156
2025/20261.857 189 136 220 171 265 105 177 82 225 181 72 34
Totale 4.879